Technology Transfer Office
Search
Events

From discovery to gold standard in Oncology

Institut Curie
02/07/2020
Share
Being able to forecast the next one is a tricky game of changing targets, as drug candidates or methods might be already under development within labs. Therefore, this conference aims to: Raise the awareness of all the stakeholders involved in the improvements of cancer diagnosis and therapies, Have experts from multiple domains including both scientific and business perspective sharing their experience and their opinions on the future of oncology,Promote discussion on the future of therapies and networking among the participants.
DeepTechWeekCurie2020
09 Mar
From discovery to gold standard in Oncology Deep Tech Week@Institut Curie
Location: 12, rue Lhomond 75005 Paris
Organizer: Institut Curie - Hello Tomorow

The identification of these breakthrough innovations at the earliest stage is the grail of most stakeholders at the interface of research and development. The goal of this workshop is to share practice from France and aboard ensuring that the next big thing would be properly identified, protected, maturated and transferred from academia to the industry ensuring a successful development that would reach researchers and patients at some point.

Researchers, clinicians and industries have witnessed the emergence of broad range of innovations over the past years in Oncology, including but not limited to cell and gene therapies, machine learning and immunotherapy.

Being able to forecast the next one is a tricky game of changing targets, as drug candidates or methods might be already under development within labs. Therefore, this conference aims to:

  • Raise the awareness of all the stakeholders involved in the improvements of cancer diagnosis and therapies.

  • Have experts from multiple domains including both scientific and business perspective sharing their experience and their opinions on the future of oncology.

  • Promote discussion on the future of therapies and networking among the participants.

    This event is organised by Institut Curie with the support of FINDMED and PSL

13h30 Introduction

  • Sarah Pedroza, Co-managing Director - Hello Tomorrow
  • Amaury Martin, Head of tech transfer office - Institut Curie

The place of Tech transfer in France and abroad - hosted by Isabelle Peltier-Bressac, consultant, former TTO Director

  • Amaury Martin, Head of tech transfer office - Institut Curie
  • Cédric Denis-Remi, Vice President Innovation PSL
  • Eliane Piaggo, Research Team Leader in Translational Immunology - Institut Curie
  • Stephanie Marrus, Director of the Entrepreneurship Center - UCSF

Tech transfer option: entrepreneurship or license ? hosted by Bruno Rostand, Innovation & Entrepreneurship Director - PSL

  • Jérémie Weber, Start-up, licence and industrial parternships Manager - Institut Curie
  • To be confirmed
  • To be confirmed

Coffee Break

From discovery to early stage clinical trial

  • Anne Horgan, Partner – Advent
  • To be confirmed
  • Manuel Rodriguez, Oncologist at Institut Curie

16h55: From innovation to gold standard hosted by Amaury Martin, Head of tech transfer office - Institut Curie

  • Voisin Consulting Life science
  • Jean Marc PINGUET, National Market Access and Pricing Director, Personalized Healthcare Director - Roche France
  • Sylvie Bonvalot, Visceral and digestive Surgeon - Institut Curie
  • To be confirmed

17h30: Conclusion

Cocktail & Networking

For more information, contact the organizer: timothe.cynober@curie.fr